Delivery Order SPE2DB20D2001-SPE2DB23FM68V
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,576.57 firm fixed-price contract is for the delivery of 4557876902 UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $17,717.97 and a completion date of September 14, 2023. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
- This is a $43,711.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,562,473,580 units of the prescription drug UROXATRAL 10 mg tablets. The contract has an ultimate completion date of October 16, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559576181 - UROXATRAL 10 MG TABLET 100S. The firm-fixed-price contract has a ceiling value of $2,599.00 and a completion date of January 12, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $27,272.45 and a period of performance through October 18, 2023. It is a firm-fixed-price contract and was not set aside for any specific business classification....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product, at a firm fixed price of $5,107.17. The contract has an ultimate completion date of October 25, 2024 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The $11,916.73 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,385.11 award is for the supply of UROXATRAL 10 MG TABLET 100S, a prescription medication. The contract has a completion date of July 25, 2024. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The contract, valued at $22,588.35, is a firm fixed-price delivery order awarded without any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,892.97, is for the delivery of 4562911417 UROXATRAL 10 MG TABLET 100S. The contract has a completion date of November 28, 2023, and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The contract is...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM68VDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $20,208.61 firm fixed-price contract is for the delivery of UROXATRAL 10 MG TABLET 100S, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of August 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA valued at $999,999,999, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 8/16/23 |